Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma

Anticancer Research

Volumn 19, Issue 1 B, 1999, Pages 703-707

  Pulkkinen, Jaakko O ^a   Klemi, Pekka ^b   Martikainen, Paula ^b   Grénman, Reidar ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Clinical outcome; Head and neck cancer; Immunohistochemistry; Nucleolar organiser region; Prognostic factor; Squamous cell carcinoma; TUNEL

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CHROMOSOME NOR; FEMALE; GLOTTIS; HUMAN; HUMAN TISSUE; KERATINIZATION; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032897061     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Raitiola HS anl Pukander JS: Changing trends in the incidence of laryngeal cancer. Acta Oncol 36: 33-36, 1997.
2. Falk RT, Pickle LW, Brown LM, Mason TJ, Puffler PA, and Fraumeni JFJ: Effect of smoking and alcohol consumption on laryngeal cancer risk in coastal Texas. Cancer Res 49: 4024-4029, 1989.
3. Hong WK, Lippman SM, and Wolf GT: Recent advances in head and neck cancer - larynx preservation and cancer chemoprevention. Cancer Res 53: 5113-5120, 1993.
4. Wyllie AH, Kerr JFR and Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
5. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542, 1994.
6. Vesalainen S, Lipponen P, Talja M and Syrjänen K: Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 30A: 1797-1803, 1994.
7. Lipponen PK and Aaltomaa S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis, J Pathol. 173. 333-339, 1994.
8. Lipponen P, Aaltomaa S, Kosma V-M and Syrjänen K: Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30A: 2068-2073, 1994.
9. Hellquist HB: Apoptosis in epithelial hyperplastic laryngeal lesions. Acta Otolaryngol (Stockh). Suppl 527: 25-29, 1997.
10. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
11. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA and Sidransky D: Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 712-717, 1995.
12. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-10, 1994.
13. Dursun G, Sak SD, Akyol G, Dursun A, Erekul S, Demirelle A and Akiner M Overexpression of p53 in laryngeal carcinoma: clinicopathological implications. EarNose Throat J 74: 645-648, 1995.
14. Nadal A, Campo E, Pinto J, Mallofre C, Palacin A, Arias C, Traserra J and Cardesa A: p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J Pathol 175: 181-188, 1995.
15. Salam MA, Crocker J and Morris A: Over-expression of tumour suppressor gene p53 in laryngeal squamous cell carcinomas and its prognostic significance. Clin Otolaryngol 20: 49-52, 1995.
16. Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD and Franklin WA. Correlation of tumor markers p53, Bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 122: 627-632, 1996.
17. Hirvikoski P, Kumpulainen E, Virtaniemi J, Johansson R, Haapasalo H, Marin S, Halonen P, Helin H, Raitiola H, Pukander J, Kellokumpu-Lehtinen P and Kosma VM. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol 15: 3111 -3120, 1997.
18. Nagata S: Apoptosis by death factor. Cell 88: 355-365, 1997.
19. Lipponen P, Eskelinen M and Syrjanen K: Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma, Br J Cancer 71: 1-5, 1995.
20. Derenzini M, Pession A and Trere D: Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Invest 63: 137-140, 1990.
21. Pich A, Pisani P, Kzengli M, Cappello N and Navone R: Argyrophilic nucleolar organiser region counts and prognosis in pharyngeal carcinoma. Br J Cancer 64: 327-332, 1991.
22. Xie X, Stenersen TC, Clausen OPF and Boysen M: Nucleolar organizer regions and prognosis in glottic squamous cell carcinoma. Head Neck 19: 20-26, 1997.
23. Sobin LH and Wittekind C: TNM Classification of Malignant Tumours. International Union Against Cancer (UICC). 5th edition, New York: Wiley-Liss Inc 1997, pp. 17-50.
24. American Joint Committee on Cancer (AJCC) Manual for staging of cancer, 4 edition. Philadelphia, Pa: JB Lippincott Co, 1992.
25. Shanmugaratnam K: WHO: Histological typing of tumours of the upper respiratory tract and ear. 2nd edition. Berlin: Springler-Verlag, 1991.
26. Billig H, Furuta I and Hsueh AJW: Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 133: 2204-2212, 1993.
27. Laine VJO, Nyman KM, Peuravuori HJ, Henriksen K, Parvinen M and Nevalainen TJ: Lipopolysaccharide induced apoptosis of rat pancreatic acinar cells. Gut 38: 747-752, 1996.
28. Klemi PJ, Pylkkanen L, Kiilholma P and Joensuu H: p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma. Cancer 76: 1201-1208, 1995.
29. Kaplan EL and Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc 53: 457-481, 1958.
30. Robin PE, Rockley T, Powell DJ and Reid A: Survival of cancer of the larynx related to treatment. Clin Otolaryngol 16: 193-197, 1991.
31. Vokes EE, Weichselbaum RR, Lippman SM and Hong WK: Head and neck cancer. N Engl J Med 328: 184-194, 1993.
32. Pera E, Moreno A and Galindo L: Prognostic factors in laryngeal carcinoma, Cancer 58: 928-934, 1986.
33. Wiernik G, Millard PR and Haybittle JL: The predictive value of histological classification into degrees of differentiation of squamous cell carcinoma of the larynx and hypolarynx compared with the survival of patients, Histopathology 19: 411-417, 1991.
34. Boffetta P, Merletti F, Faggiano F, Migliaretti G, Ferro G, Zanetti R and Terracini B: Prognostic factors and survival of laryngeal cancer patients from Turin, Italy. Am J Epidemiol 143: 1100-1105, 1997.
35. Carter RL: Pathology of squamous carcinomas of the head and neck. Curr Opin Oncol 3: 507-511, 1991.
36. Narayana A, Vaughan ATM, Gunaratne S, Kathuria S, Walter SA and Reddy SP: Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 82: 286-291, 1998.
37. Kropveld A, Slootweg PJ, van Mansfeld ADM and Hordijk GJ: Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis Cancer 78: 991-997, 1996.
38. Wood NB, Kotelnikov V, Caldarelli DD, Hutchinson J, Panje WR, Hegde P, Leurgans S, LaFollette S, Taylor SG, Preisler HD and Coon JS: Mutation of p53 in squamous cell cancer of the head and neck: relationship to tumor cell proliferation, Laryngoscope 107: 827-833, 1997.
39. Pulkkinen J, Penttinen M, Jalkanen M, Klemi P and Grenman R: Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol (Stockh). 117: 312-315, 1997.